Codes / ICD10CM / L90.6

L90.6 Striae atrophicae

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Striae atrophicae

Summary

Striae atrophicae, commonly known as stretch marks, are linear atrophic scars that develop due to the tearing of the dermis. These marks appear as streaks or lines on the skin and are often a result of rapid stretching of the skin beyond its normal elasticity. They can occur in various body areas and may vary in color and texture over time.

Causes

Striae atrophicae typically result from rapid skin stretching, which can be caused by factors such as pregnancy, growth spurts during adolescence, significant weight changes, or sudden muscle gain. Hormonal changes, particularly increased cortisol levels, may also contribute to their development by weakening the skin's collagen and elastin fibers.

Risk Factors

  • Rapid weight gain or loss, which stretches the skin abruptly.
  • Pregnancy, especially in the later stages when the abdomen expands quickly.
  • Adolescence, due to growth spurts that outpace skin elasticity.
  • Genetic predisposition, as some individuals are more prone to developing stretch marks.
  • Prolonged use of corticosteroid medications, which can reduce skin elasticity.

Symptoms

  • Linear, depressed streaks or bands on the skin, often pink, red, or purple initially, fading to white or silver over time.
  • Thinner, atrophic skin in the affected areas, with a slightly different texture compared to surrounding skin.
  • No significant pain or itching, though some individuals may experience mild discomfort during the early stages.

Diagnosis

Diagnosis is primarily based on clinical examination of the skin, focusing on the characteristic linear, atrophic appearance of the lesions. A patient's history of rapid skin stretching or hormonal changes may also support the diagnosis. In most cases, no additional tests are required, but a biopsy may be considered if the presentation is atypical.

Treatment Options

Treatment options for striae atrophicae are limited and primarily focus on improving appearance rather than reversing the condition. Topical treatments, such as retinoids or hyaluronic acid, may be used to enhance skin texture. Laser therapy or microdermabrasion can help reduce the visibility of newer marks. In severe cases, cosmetic procedures like microneedling or surgical excision may be considered, though results vary.

Prognosis and Follow-Up

Striae atrophicae are generally benign and do not pose a health risk. Over time, the marks often fade and become less noticeable, though they typically do not disappear completely. Follow-up is usually not necessary unless the patient seeks cosmetic improvement or experiences unusual symptoms, such as pain or rapid changes in appearance.

Complications

Complications from striae atrophicae are rare. However, in some cases, the marks may cause cosmetic concerns or mild psychological distress. There is no increased risk of skin cancer or other serious conditions associated with these lesions.

Lifestyle & Prevention

  • Maintaining a healthy weight and gradual weight changes can help reduce the risk of developing stretch marks.
  • Keeping the skin moisturized with emollients may improve elasticity, though this does not prevent marks entirely.
  • Avoiding excessive sun exposure and using sunscreen can help prevent hyperpigmentation of newer marks.
  • Regular exercise and a balanced diet support overall skin health.

When to Seek Professional Help

Seek medical attention if the stretch marks are accompanied by pain, itching, or rapid changes in appearance, as these may indicate an underlying condition. Consult a healthcare provider if the marks are widespread, appear suddenly, or are associated with other symptoms like bruising or skin thinning.

Tips for Medical Coders

When coding for striae atrophicae (L90.6), ensure documentation supports the diagnosis, including the location and appearance of the lesions. Note any associated factors, such as pregnancy or rapid weight changes, as these may be relevant for clinical context. Avoid using this code for other atrophic skin conditions without clear differentiation.

Book a walkthrough

L90.6 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.